([M - Cl]+, 100%). Anal. Calcd for C22H20ClN3O: C, 69.93; H,
5.33; N, 11.12. Found: C, 69.77; H, 5.50; N, 11.04.
125.6 (Ar), 122.6 (NCH), 122.2 (NCH), 120.8 (Ar), 56.8 (CH2),
35.2 (CH3). IR (neat): 3152 (w), 1601 (s), 1580 (s), 1558 (s), 1486
(m), 1445 (m), 1374 (s), 1296 (m), 1235 (m), 1075 (m), 754 (s), 693
(s), 534 (m), 502 (m) cm-1. ESI-MS: m/z 487 ([M + H]+, 100%),
216 ([ligand]+). Anal. Calcd for C24H24N6NiO2·H2O: C, 57.06; H,
5.19; N, 16.63. Found: C, 56.80; H, 5.51; N, 16.39.
1-(Benzimidazol-2-ylmethyl)-3-benzylimidazolium chloride (3).
A mixture of 2.37 g N-benzylimidazole (15.0 mmol) and 2.50 g
2-chloromethylbenzimidazole (15.0 mmol) in 20 mL dry 1,4-
dioxane was stirred at 100 ◦C for 48 h. The reaction mixture was
cooled and the off-white precipitate that had formed was collected
by filtration, washed with THF and diethyl ether and dried in
vacuo. The compound was further purified by recrystallization
from MeOH/diethyl ether.
Yield: 4.13 g (85%). 1H NMR (300 MHz, D2O, 300 K): d 9.63
(s, 1H, NCHN), 7.97 (s, 1H, CHIm), 7.90 (s, 1H, CHIm), 7.58 (m,
2H, CHBim), 7.50–7.35 (m, 5H, Ar-H), 7.24 (m, 2H, CHBim), 5.85
(s, 2H, CH2), 5.52 (s, 2H, CH2). 13C NMR (75 MHz, D2O, 300
Bis(1-benzyl-3-(N-phenylamidocarbonylmethyl)benzimidazol-2-
ylidene)nickel(II) (6). This compound was synthesized accord-
ing to the procedure given for 5a, starting from 1.13 g ben-
zimidazolium salt 2 (3.0 mmol), 1.23 g potassium carbonate
(9.0 mmol) and 0.19 g dry NiCl2 (1.5 mmol) in 40 mL DMF.
The complex was purified by repeated recrystallization from
dichloromethane/diethyl ether.
Yield: 0.78 g (70%). 1H NMR (300 MHz, DMSO-d6, 300 K) d
7.94 (d, J = 8 Hz, 2H, Ar-H), 7.53 (d, J = 8 Hz, 2H, Ar-H), 7.40
(t, J = 8 Hz, 2H, Ar-H), 7.29 (t, J = 8 Hz, 2H, Ar-H), 7.21 (m,
6H, Ar-H), 6.95-6.70 (m, 14H, Ar-H), 5.61 (m, 4H, CH2), 4.85 (d,
J = 16 Hz, 2H, CH2), 4.58 (d, J = 16 Hz, 2H, CH2). 13C NMR
=
K): d 147.8 (N C(CH2)N), 137.3 (NCHN), 134.7 (2 ¥ Cq), 129.0
(Ar), 128.7 (Ar), 128.4 (Ar), 123.7 (NCH), 122.6 (Ar), 52.0 (CH2),
46.2 (CH2). IR (neat): 3050 (w), 2459 (w), 1559 (m) 1426 (m), 1331
(w), 1270 (w), 1218 (w), 1161 (m), 1012 (w), 839 (w), 797 (m), 741
(s), 700 (s), 635 (m), 618 (m) cm-1. ESI-MS: m/z 289 ([M - Cl]+,
100%). Anal. Calcd for C18H16ClN4·2H2O: C, 60.08; H, 5.60; N,
15.57. Found: C, 59.95; H, 5.51; N, 15.55.
=
(75 MHz, DMSO-d6, 300K) d 179.5 (Ni–C), 166.4 (C O), 146.4
(Cq), 136.2 (Cq), 134.5 (Cq), 133.8 (Cq), 128.7 (Ar), 127.7 (Ar),
126.2 (Ar), 126.1 (Ar), 125.7 (Ar), 123.8 (Ar), 123.4 (Ar), 121.2
(Ar), 111.4 (Ar), 110.6 (Ar), 53.9 (CH2), 49.8 (CH2). IR (neat):
3131 (w), 1603 (s), 1581 (s), 1570 (s), 1486 (m), 1446 (s), 1362 (s),
1220 (m), 1078 (m), 1026 (m), 970 (w), 754 (m), 739 (s), 722 (m),
693 (s) cm-1. ESI-MS: m/z 739 ([M + H]+, 100%). Anal. Calcd
for C44H36N6NiO2·1.5H2O: C, 68.94; H, 5.13; N, 10.96. Found: C,
69.09; H, 5.08; N, 10.94.
1-(Benzimidazol-2-ylmethyl)-3-benzylbenzimidazolium chloride
(4). This ligand precursor was prepared following the pro-
cedure given for imidazolium salt 3, starting from 2.08 g
N-benzylbenzimidazole (10 mmol) and 1.67 g 2-chloromethyl-
benzimidazole (10 mmol) in 15 mL dry 1,4-dioxane.
Yield: 1.95 g (52%). 1H NMR (300 MHz, D2O, 300 K): d 9.79
(s, 1H, NCHN), 7.92 (m, 1H, Ar-H), 7.70 (m, 5H, Ar-H), 7.54 (m,
7H, Ar-H), 6.36 (s, 2H, CH2), 5.80 (s, 2H, CH2). The NH was not
observed. 13C NMR (75 MHz, D2O, 300 K): d 146.3 (NC(CH2)N,
143.6 (NCHN), 133.7 (Cq), 133.3 (Cq), 132.2 (2 ¥ Cq), 130.5 (Ar),
129.7 (Ar), 129.1 (Ar), 128.8 (Ar), 127.2 (Ar), 115.6 (Ar), 115.3
(2 ¥ Ar), 113.7 (Ar), 52.2 (CH2), 43.9 (CH2). IR (neat): 2969 (w),
2485 (w), 1617 (w), 1555 (m), 1458 (w), 1428 (w), 1376 (w), 1220
(w), 1181 (m), 1027 (w), 880 (m), 754 (s), 710 (s), 619 (m), 597
(m) cm-1. ESI-MS: m/z 339 ([M - Cl]+, 100%). Anal. Calcd for
C22H19ClN4·1.8H2O: C, 64.88; H, 5.59; N, 13.76. Found: C, 64.86;
H, 5.58; N, 13.95.
Bis(1-(benzimidazolato-2-ylmethyl)-3-benzylimidazol-2-ylidene)-
nickel(II) (7). This complex was obtained following the
procedure given for complex 5a, starting from 0.97 g imidazolium
salt 3 (3.0 mmol), 1.23 g potassium carbonate (9.0 mmol) and
0.19 g dry NiCl2 (1.5 mmol) in 40 mL DMF. The complex was
purified by recrystallization from dichloromethane/diethyl ether.
Yield: 0.74 g (78%). 1H NMR (300 MHz, CDCl3, 300 K): d 7.68
(d, J = 8 Hz, 2H, Ar-H), 7.45–7.05 (m, 12H, Ar-H), 6.93 (t, J =
8 Hz, 2H, Ar-H), 6.78 (m, 3H, Ar-H), 6.42 (m, 3H, Ar-H), 5.66
(d, J = 15 Hz, 2H, CH2), 5.19 (d, J = 15 Hz, 2H, CH2), 3.93 (d,
J = 16 Hz, 2H, CH2), 3.80 (d, J = 16 Hz, 2H, CH2). 13C NMR
(75 MHz, CDCl3, 300K): d 171.2 (Ni–C), 155.5 (Cq), 146.2 (Cq),
144.1 (Cq), 136.3 (Cq), 128.8 (Ar), 127.9 (Ar), 127.3 (Ar), 121.6
(Ar), 121.1 (Ar), 120.2 (Im–C), 120.0 (Im–C), 118.8 (Ar), 113.4
(Ar), 52.5 (CH2), 50.7 (CH2). IR (neat): 3060 (w), 1605 (w), 1446
(m), 1393 (m), 1304 (w), 1270 (m), 1338 (w), 1158 (w), 857 (w), 741
(s), 726 (s), 702 (s) cm-1. ESI-MS: m/z 633 ([M + H]+, 100%). Anal.
Calcd for C36H30N8Ni·H2O: C, 66.38; H, 4.95; N, 17.20. Found:
C, 66.43; H, 5.23; N, 17.43.
Bis(1-methyl-3-(N -phenylamidocarbonylmethyl)imidazol-2-
ylidene)nickel(II) (5a). Based on the procedure given by Liao
et al.,14 a mixture of 0.38 g imidazolium salt 1a (1.5 mmol), 97 mg
dry NiCl2 (0.75 mmol) and 0.62 g potassium carbonate (4.5 mmol)
were heated in DMF at 130 ◦C for 16 h. After cooling, the yellow
solution was filtered and the filtrate was evaporated to dryness
in vacuo. The remaining solid was dissolved in dichloromethane
and washed with water and brine. After drying with magnesium
sulfate, the solvent was reduced in volume to 10 mL. Addition
of diethyl ether yielded a bright yellow precipitate which was
collected by filtration, washed with diethyl ether and dried in
vacuo. The complex was purified by repeated recrystallization from
methanol/hexane.
Yield: 0.27 g (73%). 1H NMR (300 MHz, DMSO-d6, 300K) d
7.52 (d, J = 1.5 Hz, 2H, NCH), 7.25 (d, J = 7.5 Hz, 4H, Ar-H),
7.21 (d, J = 1.5 Hz, 2H, NCH), 6.91 (t, J = 7.5 Hz, 4H, Ar-H), 6.75
(t, J = 7.5 Hz, 2H, Ar-H), 5.71 (d, J = 14.5 Hz, 2H, CH2), 4.31
(d, J = 14.5 Hz, 2H, CH2), 3.13 (s, 6H, CH3). 13C NMR (75 MHz,
DMSO-d6, 300K) d 166.8 (Cq), 165.5 (Cq), 147.2 (Cq), 126.5 (Ar),
Bis(1-(benzimidazolato-2-ylmethyl)-3-benzylbenzimidazol-2-
ylidene)nickel(II) (8). This compound was synthesized following
the procedure given for complex 5a, starting from 1.13 g benzim-
idazolium salt 4 (3.0 mmol), 0.19 g dry NiCl2 (1.5 mmol), 1.23 g
potassium carbonate (9.0 mmol) in 40 mL DMF. Recrystallization
from chloroform/diethyl ether yielded the pure compound.
Yield: 0.67 g (61%). 1H NMR (300 MHz, CDCl3, 300 K): d 7.55
(d, 2H, J = 8 Hz, Ar-HBim), 7.43 (d, 2H, J = 8 Hz, Ar-HBim-), 7.29
(t, 2H, J = 8 Hz, Ar-HBim), 7.25–7.05 (m, 14H, Ar-H), 6.75 (dt,
2H, J = 1 Hz, J = 8 Hz, Ar-HBim-), 6.42 (dt, 2H, J = 1 Hz, J =
8 Hz, Ar-HBim-), 6.08 (d, 2H, J = 8 Hz, Ar-HBim-), 5.92 (d, 2H,
This journal is
The Royal Society of Chemistry 2009
Dalton Trans., 2009, 6948–6955 | 6953
©